Comparative effects of selective and non-selective nitric oxide synthase inhibition in gentamicin-induced rat

R Ghaznavi1, M Kadkhodaee

  • 1Department of Physiology, School of Medicine, Tehran University of Medical Sciences, 14174 Tehran, Iran.

Archives of Toxicology
|October 14, 2006
PubMed

Insights

Selective inhibition of inducible nitric oxide synthase (iNOS) protects against gentamicin-induced nephrotoxicity. Blocking all nitric oxide synthase (NOS) isoforms, however, worsens kidney injury, highlighting iNOS as a therapeutic target.

Area of Science:

  • Nephrology
  • Pharmacology
  • Toxicology

Background:

  • Nitric oxide synthase (NOS) isoforms play differential roles in kidney injury.
  • Endothelial NOS (eNOS) activity can restore renal function, while inducible NOS (iNOS) activation exacerbates kidney failure.

Purpose of the Study:

  • To investigate the protective effects of selective inducible NOS (iNOS) blockade against gentamicin (GM)-induced nephrotoxicity in rats.

Main Methods:

  • Rats were divided into four groups: control, GM-only, GM + non-selective NOS inhibitor (L-NAME), and GM + selective iNOS inhibitor (L-NIL).
  • Renal function was assessed by measuring serum creatinine, creatinine clearance (as a marker of glomerular filtration rate - GFR), and urine N-acetyl-b-D-glucose aminidase (NAG) activity.
  • Kidney tissues were examined histologically for tubular damage.

Main Results:

  • Selective iNOS inhibition with L-NIL prevented the decrease in GFR and increase in creatinine caused by GM.
  • Non-selective NOS inhibition with L-NAME worsened GM-induced nephrotoxicity, including reduced GFR, elevated creatinine, and increased enzyme release.
  • Histological analysis revealed reduced tubular damage in rats treated with L-NIL compared to GM-only or GM + L-NAME groups.

Conclusions:

  • Selective inhibition of iNOS demonstrates a protective effect against gentamicin-induced nephrotoxicity.
  • Non-selective NOS inhibition exacerbates kidney injury, underscoring the specific detrimental role of iNOS in this model.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...